Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

BIO Expresses Support for Tax Extender Legislation

Dec 16 2015
BIO today welcomed legislation to extend critical tax incentives that are important to biotechnology companies. The legislation would make permanent the important Research & Development Tax Credit.

BIO and PPMD Launch Initiative to Share Best Practices on Patient Preference Studies

Dec 8 2015
BIO and Parent Project Muscular Dystrophy (PPMD) announce the launch of a new initiative designed to share best practices for the development of disease-specific patient preference studies. Through this effort, BIO and PPMD will produce a document outlining key considerations to help guide stakeholders on the development of patient preference studies, which can be used for multiple purposes, including informing the drug development and regulatory processes...

Biotech Leader Provides Testimony Before House Capital Markets Subcommittee

Dec 2 2015
BIO supports legislation to follow up on the success of the JOBS Act

BIO Applauds Reps. Sinema and Fitzpatrick for Introducing the Fostering Innovation Act

Dec 1 2015
Bill would extend a cost-saving JOBS Act provision

BIO Statement on Hepatitis C Medicines Report from Senators Grassley and Wyden

Dec 1 2015

Washington, D.C. (December 1, 2015) – The following statement regarding the report released today by Senators Grassley and Wyden may be attributed to BIO Senior Vice President of...

BIO Statement on EPA Final Rule for 2014, 2015 and 2016 Renewable Fuel Standards

Nov 30 2015
The final rule for the 2014, 2015 and 2016 Renewable Fuel Standards (RFS), issued today by the Environmental Protection Agency (EPA), is an unnecessary, unlawful about face for a program that was successfully driving development of cleaner biofuel technologies and reduction of U.S. greenhouse gas emissions. The rule undermines the goals of the statute, and it will continue to undercut investment in advanced and cellulosic biofuels and increase greenhouse gas emissions in the transportation fuel sector, BIO said today.

BIO Applauds Administration’s Support for Science-based Food Policy

Nov 23 2015
The Food and Drug Administration (FDA) has officially announced that it has rejected petitions from public interest groups calling for mandatory labeling of foods produced with genetic engineering.

BIO Statement on HHS Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

Nov 20 2015

Washington, D.C. (November 20, 2015) – The Biotechnology Industry Organization (BIO) released the following statement regarding today’s U.S. Department of Health and Human Services...

BIO Applauds FDA Approval of GE Salmon, Technology Provides Sustainable, Nutritious Food

Nov 19 2015
After conducting a thorough and rigorous regulatory review, the U.S. Food and Drug Administration (FDA) has approved the genetically engineered (GE) AquAdvantage® Salmon for commercial marketing.

BIO Releases Seven Proposed Topics for HHS Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

Nov 18 2015
BIO released a list of seven proposed topics for the November 20th U.S. Department of Health and Human Services (HHS) Forum on Pharmaceutical Innovation, Access, Affordability and Better Health. The consideration of these topics at the Forum will help to ensure that patients have access to the most innovative new treatments and cures.